CD274 and cancer: In parallel, dysregulation of immune checkpoint pathways—particularly downregulation of PD-1 on T cells and PD-L1 on antigen-presenting cells—mirrors mechanisms observed in autoimmunity and cancer, where impaired checkpoint control leads to sustained T cell activation [23].